SIRT1 and Peritoneal Fibrosis: It is worth to point out that SIRT1-modified hUCMSCs have more potent anti-fibrosis ability than the hUCMSCs, indicating SIRT1-overexpressed hUCMSCs possess better therapeutic ability for the treatment of peritoneal fibrosis.